Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $886.47 billion, total revenue of $172.71 billion and a weighted average PE ratio of 49.00.
Market Cap
886.47B
Revenue
172.71B
Profits
18.09B
PE Ratio
49.00
Profit Margin
10.47%
Dividend Yield
0.20%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 245.99B | 1.03% | 2,345,631 | 46.34B |
| 2 | DHR | Danaher Corporation | 155.75B | 0.21% | 3,404,584 | 25.11B |
| 3 | NTRA | Natera, Inc. | 56.33B | -0.03% | 1,690,565 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 46.61B | -1.16% | 3,238,623 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 44.09B | -0.83% | 1,116,576 | 16.98B |
| 6 | WAT | Waters Corporation | 41.32B | -1.21% | 743,554 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 41.13B | 0.10% | 364,187 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 38.56B | 3.20% | 2,300,938 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 29.90B | 0.11% | 238,567 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.72B | -0.75% | 1,129,616 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 24.65B | -2.43% | 909,589 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 23.66B | -0.48% | 1,432,141 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.23B | -2.07% | 275,740 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 15.86B | -0.84% | 2,244,120 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.24B | -2.73% | 1,594,221 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.65B | -1.92% | 1,064,824 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.04B | 0.05% | 3,034,963 | 2.10B |
| 18 | RDNT | RadNet, Inc. | 5.76B | -1.04% | 560,678 | 2.27B |
| 19 | BLLN | BillionToOne, Inc. | 5.40B | -1.42% | 397,671 | 397.41M |
| 20 | SHC | Sotera Health Company | 5.22B | -2.14% | 1,758,474 | 1.22B |
| 21 | GRAL | GRAIL, Inc. | 4.90B | 1.12% | - | 165.26M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.45B | -0.61% | 1,079,839 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.52B | 1.06% | 1,525,526 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 2.81B | -3.86% | 1,906,170 | 458.09M |
| 25 | WGS | GeneDx Holdings Corp. | 2.54B | -6.17% | 1,045,717 | 454.43M |
| 26 | NEO | NeoGenomics, Inc. | 2.36B | -2.81% | 2,911,644 | 766.30M |
| 27 | PSNL | Personalis, Inc. | 1.75B | -0.06% | 1,123,841 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.69B | -4.62% | 578,478 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.27B | -1.73% | 1,783,717 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.07B | 0.14% | 348,305 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 585.25M | -1.76% | 190,336 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 383.56M | -0.25% | 1,658,065 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 309.04M | 4.05% | 68,956 | 102.94M |
| 34 | XGN | Exagen Inc. | 207.13M | -2.17% | 383,727 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 158.99M | -8.36% | 24,077 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 127.95M | -5.56% | 597,260 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 110.97M | - | 242,502 | 537.08K |
| 38 | MDXH | MDxHealth SA | 57.78M | 0.93% | 109,131 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 42.68M | -9.25% | 39,717 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 10.42M | -1.10% | 12,351 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 9.75M | 4.33% | 56,771 | - |
| 42 | XWEL | XWELL, Inc. | 7.75M | 1.12% | 27,853 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 4.29M | -7.24% | 207,877 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 3.05M | -3.20% | 93,238 | 466.30K |